Laiqiang Huang
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 30
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 6
- Molecular Medicine top 2%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 13
- Graphene and Nanomaterials Applications 10
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 10
- Photosynthetic Processes and Mechanisms 7
-
- Plant and animal studies 8
-
- Dendrimers and Hyperbranched Polymers 6
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Laiqiang Huang
100 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Biomaterials 1.9k
- Pharmaceutical Science 614
- Molecular Medicine 191
- Biomedical Engineering 1.4k
- Molecular Biology 2.0k
Countries citing papers authored by Laiqiang Huang
This map shows the geographic impact of Laiqiang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laiqiang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laiqiang Huang more than expected).
Fields of papers citing papers by Laiqiang Huang
This network shows the impact of papers produced by Laiqiang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laiqiang Huang. The network helps show where Laiqiang Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laiqiang Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 33 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 10 | |
| 9 | 2018 | 15 | |
| 10 | 2018 | 13 | |
| 11 | 2015 | 216 | |
| 12 | 2014 | 61 | |
| 13 | 2013 | 245 | |
| 14 | 2012 | 9 | |
| 15 | 2011 | 22 | |
| 16 | 2010 | 6 | |
| 17 | 2009 | 125 | |
| 18 | 2009 | 115 | |
| 19 | 2006 | 71 | |
| 20 | 1999 | 124 |
About Laiqiang Huang
Laiqiang Huang is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology, having authored 101 papers that have together received 5.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (13 papers), RNA Interference and Gene Delivery (10 papers), Graphene and Nanomaterials Applications (10 papers), Plant and animal studies (8 papers), Photosynthetic Processes and Mechanisms (7 papers), Advanced Drug Delivery Systems (6 papers) and Dendrimers and Hyperbranched Polymers (6 papers). The work is most often cited by research in Biomaterials (1.9k citations), Pharmaceutical Science (614 citations) and Molecular Medicine (191 citations). Laiqiang Huang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lin Mei, Xiaowei Zeng, Si‐Shen Feng, Yi Zheng, Tao Wei, Teng Wang, Hongbo Chen, Junpeng Nie, Chaoyu Liang and Gan Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.